ImmunoPET to help stratify patients for targeted therapies and to improve drug development

Françoise Kraeber-Bodere (1) , Clément Bailly (1) , Michel Chérel (1, 2) , Jean-François Chatal (2)

1 CRCNA - Centre de Recherche en Cancérologie Nantes-Angers
2 Institut de Recherche Public - ARRONAX - (GIP) Groupement d'Intérêt Public [Saint-Herblain]

no abstract

Domaines: Cancer

Françoise Kraeber-Bodere, Clément Bailly, Michel Chérel, Jean-François Chatal. ImmunoPET to help stratify patients for targeted therapies and to improve drug development. European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 (12), pp.2166-2168. ⟨10.1007/s00259-016-3458-6⟩. ⟨inserm-01809742⟩